
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Sponsored
Sponsored
2026-09-15HEPASCHEDULE 13GKenneth Rickel Acquires 5.7% Passive Stake in Hepion Pharmaceuticals, Inc.MEDIUM
On September 15, 2026, Kenneth Rickel filed a Schedule 13G with the SEC, reporting a new 5.7% ownership stake in Hepion Pharmaceuticals, Inc. (HEPA). Rickel beneficially owns 5,250,000 shares of common stock, which includes 2,000,000 shares issuable upon the exercise of warrants. This filing follows an event date of Au...
Biotechnologyownership +5.70%
Sponsored
2026-09-15Hepion Pharmaceuticals, Inc.SCHEDULE 13GKenneth Rickel Acquires 5.7% Passive Stake in Hepion Pharmaceuticals, Inc.DuplicateMEDIUM
On September 15, 2026, Kenneth Rickel filed a Schedule 13G with the SEC, reporting a new 5.7% ownership stake in Hepion Pharmaceuticals, Inc. (HEPA). Rickel beneficially owns 5,250,000 shares of common stock, which includes 2,000,000 shares issuable upon the exercise of warrants. This filing follows an event date of Au...
Biotechnologyownership +5.70%